Dr. Gregory F. Sonnenberg has been recognized for his “innovative research program which continues to make seminal scientific contributions at the interface of immunology and microbiology.”
A team of intercampus investigators has received a $3.65 million grant from the NIH to develop an inexpensive method for accurately diagnosing UTIs in kidney transplant patients by carrying out molecular profiling of cell-free DNA in urine.
In this paper, which reflected further analysis stemming from their previous paper published in Nature Communications (December 2019), 168 kidney transplant recipients, who provided 510 fecal specimens, were evaluated.
The Research Retreat will provide a distinct forum to bring together a diverse range of established and emerging faculty and trainees and experts in complimentary fields to foster and expand research efforts in the Weill Department of Medicine.
Investigators at Weill Cornell Medicine and NewYork-Presbyterian are recruiting 1,000 asymptomatic health care workers for a study on COVID-19 that seeks to answer the question: why do some people become severely ill, while others have no symptoms?
This prestigious research award is a 5-year grant in the amount of $1.1 million and will support development and testing of Dr. Goyal’s novel strategy for deprescribing medication in older adults with heart failure.
These awards are presented by The Executive Committee on Diversity and Inclusion: Drs. Linnie Golightly, Joy Howell, Said Ibrahim, Marcus Lambert, Rache Simmons.
The paper is a one-year retrospective review of the incidence of Clostridium difficile infection in NewYork-Presbyterian/Weill Cornell Medical Center inpatients.
This award is presented annually to members of the Weill Department of Medicine below the rank of professor who perform on outstanding levels in the areas of clinical and/or basic biomedical research.
Patients with the most common type of metastatic pancreatic cancer showed improved results when treated with a combination of an investigational drug, an immunotherapy drug, and chemotherapy.
